Title:
POLYMORPHS OF MAXACALCITOL AND PROCESS FOR THE PREPARATION OF MAXACALCITOL
Document Type and Number:
WIPO Patent Application WO/2012/122451
Kind Code:
A3
Abstract:
The present invention relates to Maxacalcitol polymorphs and Maxacalcitol having low residual solvent content as well as processes for their preparation. The present invention also relates to pharmaceutical compositions containing Maxacalcitol polymorphs or Maxacalcitol having low residual solvent content and treatment methods using the pharmaceutical compositions.
Inventors:
SCHWARTZ ANCHEL (IL)
WOLFMAN KOBY (IL)
RAFILOVICH-GIVON MICHAL (IL)
RADCHENKO OLEG (IL)
WOLFMAN KOBY (IL)
RAFILOVICH-GIVON MICHAL (IL)
RADCHENKO OLEG (IL)
Application Number:
PCT/US2012/028426
Publication Date:
January 17, 2013
Filing Date:
March 09, 2012
Export Citation:
Assignee:
TEVA PHARMA (US)
TEVA PHARMA (US)
SCHWARTZ ANCHEL (IL)
WOLFMAN KOBY (IL)
RAFILOVICH-GIVON MICHAL (IL)
RADCHENKO OLEG (IL)
TEVA PHARMA (US)
SCHWARTZ ANCHEL (IL)
WOLFMAN KOBY (IL)
RAFILOVICH-GIVON MICHAL (IL)
RADCHENKO OLEG (IL)
International Classes:
C07C401/00; A61K31/59; A61P17/00
Other References:
SHIMIZU, H. ET AL.: "Industrial Synthesis of Maxacalcitol, the Antihyperparathyroidism and Antipsoriatic Vitamin D3 analogue Exhibiting Low Calcemic Activity", ORGANIC PROCESS RESEARCH & DEVELOPMENT, vol. 9, 2005, pages 278 - 287, XP002675913
Attorney, Agent or Firm:
BIRDE, Patrick J. et al. (One BroadwayNew York, NY, US)
Download PDF:
Previous Patent: PEPTIDE DEFORMYLASE INHIBITORS
Next Patent: 2,4 SUBSTITUTED PYRIMIDINEDIAMINES FOR USE IN DISCOID LUPUS
Next Patent: 2,4 SUBSTITUTED PYRIMIDINEDIAMINES FOR USE IN DISCOID LUPUS